Washingtn University Physician Netwrk Campus Bx 8221 4240 Duncan Ave, Ste. 301 St. Luis, MO 631110 Phne: (314) 273-0600 August 5, 2016 RE: WUPN/CHA Grup Purchasing Prgram New GSK Price Change Ntificatin Effective 7-1-2016 Dear Practice Manager: Please be advised f the fllwing GSK price and rebate changes effective 7/1/2016. The fllwing pricing sheets are attached fr yur cnvenience. Please replace ld cpies with the attachments prvided. If yu have questins abut the WUPN/CHCA grup purchasing prgram, please cntact either Pat Lvins at 314-273-0484 r, Jack Federhfer at 314-273-0473 fr assistance. Please cntact yur GSK Representative, Angela Camern at 314-265-0898 r by email at Angela.B.Camern@gsk.cm t assist yu with eligibility in rebate r discunt calculatins f yur current purchases. As a reminder, rebates are prvided back t the practice directly frm GSK n a semiannual basis. The return f the Administratin Service Fees, are returned t yur practice by WUPN annually each June. Sincerely, Patricia Lvins WUPN, Prfessinal Relatins Specialist [1]
Washingtn University Physician Netwrk Campus Bx 8221 4240 Duncan Ave, Ste. 301 St. Luis, MO 631110 Phne: (314) 273-0600 Child Health Advantage Prgram s GlaxSmithKline (GSK) Cntract Highlights Cntract Effective Dates: 1/1/2015 thrugh 6/30/2017 Pediatric and Adult vaccines frm GlaxSmithKline: Pediarix (DTaP, Hep B and IPOL) Bstrix (Tdap) Cervarix (Human Papillmavirus Bivalent (Types 16 and 18) Vaccine, Recmbinant). (Nte: N lnger sld in US after 11/30/2016.) Engerix (Hep B) Adult and Pediatric Havrix (Hep A) Adult and Pediatric Infanrix (DTaP) Rtarix (Rtavirus Vaccine, Live, Oral) Kinrix [ Diptheria and Tetanus Txids and Acellular Pertussis Absrbed (DTaP) and inactivated Plivirus Vaccine ] a new cmbinatin DtaP-IV vaccine. Twinrix (Hepatitis A and Hepatitis B Vaccine) FluLaval ( Flu Vaccine) Fluarix (Flu Vaccine) Menve and Bexser - Meningcccal Vaccines Distributin f GSK Vaccines are handled thrugh several vendrs: Besse Medical Medic-Mart Curascript (aka:pririty) Seacast PSS New ecmmerce Website Service: www.gskdirect.cm Fr a cmplete list f cntracted distributrs f GSK vaccines please cntact the WUPN Prfessinal Relatins Department. Return f CHCA Administrative Fee: CHCA currently receives a 3% administrative fee frm GSK based n the net sales f GSK prducts thrugh the Child Health Advantage Prgram. CHCA, in turn, transfers 50% f the administrative fee t WUPN. If yur practice purchases thrugh the Child Health Advantage Prgram, WUPN will transfer yur practice s prtin f the CHCA administratin fee t yu. WUPN typically transfers the administratin fee amunt in June f each year. This is separate frm the rebate r upfrnt discunt that yu earn frm the purchase f vaccines. [2]
Perfrmance Criteria: Prduct Grup 1 GSK Prduct Share Perfrmance) Pediarix Infanrix Kinrix Menhibrix (purchases DECREASE Share Perfrmance) Pentacel Daptacel Quadracel Vlume Perfrmance Pertussis Vaccines Class & Cmbinatin HIB Prduct Grup 2 GSK Prduct Share Perfrmance) Engerix-B Pediatric Havrix Pediatric Rtarix Cervarix Share Perfrmance) Recmbivax Pediatric Vaqta Pediatric Cmvax Rtateq Vlume Perfrmance Pediatric Hepatitis, Rtavirus, & HPV Vaccine Class Prduct Grup 3 GSK Prduct Share Perfrmance) Bstrix Engerix-B Adult Havrix Adult Twinrix RabAvert Share Perfrmance) Adacel Recmbivax Adult Vaqta Adult Vlume Perfrmance Tdap and Adult Hepatitis Vaccine Class, Rabies & Japanese Encephalitis Vaccines Prduct Grup 4 GSK Prduct Share Perfrmance) Menve Bexser Share Perfrmance) Vlume Perfrmance Menactra Trumenba 70% Meningcccal Vaccines Class Share calculatin will be based n WAC sales data as prvided by a 3rd party data vendr. GSK reserves the right t change 3rd party data vendrs at any time at its wn discretin. [3]
Effective 7/1/2016 Pediatric Vaccines NDC Vaccine Descriptin Enhanced Cntract Price Price / Dse 2% Prmpt Pay Incl. / Dse After 3% PGB+ Rebate / Dse Engerix-B Pediatric (1) 58160-0820-11 10mcg/0.5mL Prefilled Tip-Lk Syringe w/ut needles (10 s) $110.92 $11.09 $10.87 $10.54 58160-0820-52 Single Dse 10mcg/0.5mL Vial (10 s) $110.92 $11.09 $10.87 $10.54 Havrix Pediatriac (1) 58160-0825-11 720 EL.U./0.5mL, Prefilled Tip-Lk Syringe w/ut needles (10 s) $218.22 $21.82 $21.39 $20.73 58160-0825-52 Single Dse 720 EL.U./0.5mL Vial (10 s) $218.22 $21.82 $21.39 $20.73 Infanrix (3) 58160-0810-11 0.5 ml Prefilled Tip-Lk Syringe w/ut needles (10 s) $157.85 $15.79 $15.47 $15.00 58160-0810-52 Single Dse 0.5mL Vial (10 s) $157.85 $15.79 $15.47 $15.00 HIberix (1) 58160-0818-11 Single Dse 0.5mL Vial (10) $90.27 $9.03 $8.85 $8.58 Pediarix (5) 58160-0811-52 0.5mL Prefilled Tip-Lk Syringe w/ut needles (10 s) $527.30 $52.73 $51.68 $50.09 Kinrix (4) 58160-0812-11 0.5mL Prefilled Tip-Lk Syringe w/ut needles (10 s) $377.08 $37.71 $36.95 $35.82 58160-0812-52 Single Dse 0.5mL Vial (10 s) $377.08 $37.71 $36.95 $35.82 Rtarix (1) 58160-0854-52 Oral Suspensin (10) $886.61 $88.66 $86.89 $84.23 Bstrix (3) 58160-0842-11 0.5mL Prefilled Tip-Lk Syringe w/ut needles (10 s) $306.54 $30.65 $30.04 $29.12 58160-0842-52 Single Dse 0.5mL Vial (10 s) $306.54 $30.65 $30.04 $29.12 Bexser (1) 46028-0114-01 0.5mL singe dse syringe (10's) $1,521.12 $152.11 $149.07 $144.51 46028-0114-02 0.5mL single des syringe (1) $152.11 $152.11 $149.07 $144.51 Meve 46028-0208-01 Meningcccal Cnjugate (Grups A, C, Y and W-135) (5's) $454.10 $90.82 $89.00 $86.28 Rabavert 63851-501-02 1D/KIT (1) $267.35 $26.74 $26.20 $25.40 NDC Vaccine Descriptin Adult Vaccines Enhanced Cntract Price Price / Dse 2% Prmpt Pay Incl. / Dse After 3% PGB+ Rebate / Dse Engerix-B (1) 58160-0821-11 20mcg/mL, Prefilled Tip-Lk Syringe w/ut needles (10 s) $408.41 $40.84 $40.02 $38.80 58160-0821-52 20mcg/mL, Vial (10 s) $408.41 $40.84 $40.02 $38.80 Havrix (1) 58160-0826-11 1440 EL.U./mL Prefilled Tip-Lk Syringe w/ut needles (10 s) $536.95 $53.70 $52.62 $51.01 58160-0826-52 440 EL.U./M Vial (10's) $536.95 $53.70 $52.62 $51.01 Twinrix (2) 58160-0815-11 720 EL.U./mL Prefilled Tip-Lk Syringe w/ut needles (10 s) $808.40 $80.84 $79.22 $76.80 58160-0815-52 Single Dse 720 EL.U./mL Vial (10 s) $808.40 $80.84 $79.22 $76.80 Menhibrix (2) 58160-0801-11 Single Dse Vials (10) $168.36 $16.84 $16.50 $15.99 Cervarix (1) 58160-0830-52 Cervarix 1 DS/0.5mL T-Lk N Needle Syringe 10 s LM $1,162.98 $116.30 $113.97 $110.48 Ntes: (1) Engerix-B, Havrix, Menve, Bexser, Hiberix Rtarix, and Cervarix Cntract Prices d nt include Federal Excise Tax f $0.75/dse r any applicable state taxes. (2) Twinrix Cntract Prices d nt include Federal Excise Tax f $1.50/dse r any applicable state taxes. (3) Infanrix and Bstrix Cntract Prices d nt include Federal Excise Tax f $2.25/dse r any applicable state taxes. (4) Kinrix Cntract Prices d nt include Federal Excise Tax f $3.00/dse r any applicable state taxes. (5) Pediarix Cntract Prices d nt include Federal Excise Tax f $3.75/dse r any applicable state taxes [4]
Semi-Annual Perfrmance Rebates: Participating Members will qualify fr a semi-annual cntract perfrmance rebate ( Perfrmance Rebate ) f 3% n all GSK Vaccine Prducts if required aggregate Share Requirements are btained during each semi-annual perid listed belw. Evaluatin and Pricing Perids: The evaluatin perids fr the Semi-Annual Perfrmance Rebate are as fllws: Evaluatin Perid Rebate Perid 07/01/16 thrugh 12/31/16 07/01/16 thrugh 12/31/16 01/01/17 thrugh 06/30/17 01/01/17 thrugh 06/30/17 If a Participating Member is added during a current Rebate Perid, member will be eligible t earn Perfrmance Rebates frm their effective membership date. Participating Members added during an Evaluatin Perid will be included in the market share calculatin at the beginning f the next Evaluatin Perid and will nt be included in the market share calculatin fr the then current Evaluatin perid. If a Participating Member attains the required Share Requirements, member will earn a 3% Perfrmance Rebate n all Cntract Net Sales f GSK Vaccines purchased during the Rebate Perid. Rebates will be paid apprximately sixty (60) days after the end f the Rebate Perid. Ttal payment must be equal t r greater than $100 r Perfrmance Rebate will nt be paid. Cntract Pricing: Cntract Pricing fr each pricing perid may be earned by Participating Members n GSK Vaccines listed belw, if during each crrespnding Evaluatin Perid, participating members, as a grup, achieve and maintain the required aggregate market share perfrmance level. If the participating member des nt achieve the required aggregate market share perfrmance level as required and utlined belw, the Participating Member may be mved t the GSK individual Vaccine Pricing Agreement ( ivpa ) and will n lnger be able t receive Cntract Pricing. In the event that GSK is unable t supply any f the vaccines identified belw fr an extended perid f time, then GSK may adjust Share Requirements fr applicable (Bucket) fr affected evaluatin perid. [5]